Hospital Universitario Son Espases; Servicio de Oncologia

Palma de Mallorca, Balearic Islands 07014

0 studies enrolling now · 2 studies all time

What they study most

Advanced BRAFV600 Wild-type Melanoma, Bladder Cancer

Studies at this site

• A Study of Cobimetinib Plus Atezolizumab Versus Pembrolizumab in Participants With Previously Untreated Advanced BRAFv600 Wild-Type Melanoma — Stopped early
• A Study of Atezolizumab Compared With Chemotherapy in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer [IMvigor211] — Completed